Discovery of Selective Estrogen Receptor Covalent Antagonists (SERCAs) for the treatment of ERa(WT) and ERa(MUT) breast cancer.
Ontology highlight
ABSTRACT: Discovery of Selective Estrogen Receptor Covalent Antagonists (SERCAs) for the treatment of ERa(WT) and ERa(MUT) breast cancer.
PROVIDER: PRJNA475560 | ENA |
REPOSITORIES: ENA
ACCESS DATA